• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于日本国家临床数据库的14152例食管癌患者微创食管切除术中手术设施规模对围手术期结局的影响:一项多中心队列研究

Influence of Facility Size on Perioperative Outcomes in Minimally Invasive Esophagectomy for 14 152 Patients With Esophageal Cancer Based on the Japanese National Clinical Database: A Multicenter Cohort Study.

作者信息

Oshikiri Taro, Tachimori Hisateru, Miyata Hiroaki, Kakeji Yoshihiro, Shirabe Ken

机构信息

Department of Gastrointestinal Surgery and Surgical Oncology Ehime University Graduate School of Medicine Toon Ehime Japan.

Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine Kobe University Kobe Hyogo Japan.

出版信息

Ann Gastroenterol Surg. 2025 May 1;9(5):942-951. doi: 10.1002/ags3.70027. eCollection 2025 Sep.

DOI:10.1002/ags3.70027
PMID:40922930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12414597/
Abstract

BACKGROUND

Conventional minimally invasive esophagectomy (C-MIE) is the mainstay for locally advanced esophageal cancer. However, the relationship among facility size, risk-adjusted mortality and morbidity in C-MIE remains unclear. This study aims to clarify whether C-MIE should be consolidated into high-volume centers in Japan.

METHODS

Risk models for perioperative mortality and morbidity were created using the Japanese National Clinical Database (NCD) data. NCD data registered between January 2016 and December 2020, including 14 152 C-MIE records. The developed risk models were used to estimate the ratio of expected to observed events (perioperative deaths or complications) (O/E ratio) for each facility.

RESULTS

Regarding the risk model performances, the C-indices of the perioperative mortality risk prediction models were 0.793. The O/E ratio and 95% confidence interval (CI) for perioperative mortality were facility size < 10 MIEs/year, O/E ratio: 1.368 and 95% CI: 1.140-1.597; facility size 10-29 MIEs/year, O/E ratio: 0.886 and 95% CI: 0.644-1.127; and facility size ≥ 30 MIEs/year, O/E ratio: 0. 61 and 95% CI: 0.342-0.892. Conversely, there were no significant differences in morbidity rate by facility size.

CONCLUSIONS

The risk of perioperative mortality from C-MIE was lower in hospitals with larger facilities than those with smaller facilities; therefore, consolidating patients for C-MIE in high-volume hospitals is necessary.

摘要

背景

传统微创食管癌切除术(C-MIE)是局部晚期食管癌的主要治疗方法。然而,C-MIE中医疗机构规模、风险调整后的死亡率和发病率之间的关系仍不清楚。本研究旨在阐明在日本C-MIE是否应集中于高手术量中心。

方法

使用日本国家临床数据库(NCD)数据创建围手术期死亡率和发病率的风险模型。NCD数据记录于2016年1月至2020年12月之间,包括14152条C-MIE记录。所开发的风险模型用于估计每个医疗机构预期事件与观察到的事件(围手术期死亡或并发症)的比率(O/E比率)。

结果

关于风险模型性能,围手术期死亡风险预测模型的C指数为0.793。围手术期死亡率的O/E比率和95%置信区间(CI)为:医疗机构规模<每年10例MIE,O/E比率:1.368,95%CI:1.140-1.597;医疗机构规模为每年10-29例MIE,O/E比率:0.886,95%CI:0.644-1.127;医疗机构规模≥每年30例MIE,O/E比率:0.61,95%CI:0.342-0.892。相反,不同医疗机构规模的发病率无显著差异。

结论

设施规模较大的医院进行C-MIE的围手术期死亡风险低于规模较小的医院;因此,有必要将C-MIE患者集中到高手术量医院。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/1756d1f8e9ec/AGS3-9-942-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/3415b2ed2f40/AGS3-9-942-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/6843e917fbca/AGS3-9-942-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/d9a1ecc2e526/AGS3-9-942-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/c1bbd48ecc3b/AGS3-9-942-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/1756d1f8e9ec/AGS3-9-942-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/3415b2ed2f40/AGS3-9-942-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/6843e917fbca/AGS3-9-942-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/d9a1ecc2e526/AGS3-9-942-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/c1bbd48ecc3b/AGS3-9-942-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d67c/12414597/1756d1f8e9ec/AGS3-9-942-g003.jpg

相似文献

1
Influence of Facility Size on Perioperative Outcomes in Minimally Invasive Esophagectomy for 14 152 Patients With Esophageal Cancer Based on the Japanese National Clinical Database: A Multicenter Cohort Study.基于日本国家临床数据库的14152例食管癌患者微创食管切除术中手术设施规模对围手术期结局的影响:一项多中心队列研究
Ann Gastroenterol Surg. 2025 May 1;9(5):942-951. doi: 10.1002/ags3.70027. eCollection 2025 Sep.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
4
Minimally invasive versus open esophagectomy for cancer: a systematic review and meta-analysis.微创与开放食管癌切除术治疗癌症的系统评价与荟萃分析。
Minerva Chir. 2009 Apr;64(2):121-33.
5
Interventions for preventing falls in older people in care facilities.护理机构中预防老年人跌倒的干预措施。
Cochrane Database Syst Rev. 2025 Aug 20;8:CD016064. doi: 10.1002/14651858.CD016064.
6
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.在非医疗机构分娩环境中使用缩宫素预防产后出血
Cochrane Database Syst Rev. 2016 Apr 14;4(4):CD011491. doi: 10.1002/14651858.CD011491.pub2.
9
Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.体外二氧化碳清除治疗急性低氧性呼吸衰竭:REST随机对照试验
Health Technol Assess. 2025 Jul;29(33):1-16. doi: 10.3310/GJDM0320.
10
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.

本文引用的文献

1
Mortality and failure-to-rescue after esophagectomy in the procedure-targeted National Surgical Quality Improvement Program registry.在以手术为目标的国家外科质量改进计划登记处,食管癌手术后的死亡率和救援失败率。
World J Surg. 2024 Sep;48(9):2235-2242. doi: 10.1002/wjs.12297. Epub 2024 Jul 23.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Improvement Effect of Upper Mediastinal Lymphadenectomy During Minimally Invasive Esophagectomy on the Prognosis in Squamous Cell Carcinoma: Efficacy Index and Propensity Score Matching Analyses.
微创食管癌切除术中上纵隔淋巴结清扫对鳞状细胞癌预后的改善效果:疗效指标及倾向评分匹配分析
J Am Coll Surg. 2023 Nov 1;237(5):762-770. doi: 10.1097/XCS.0000000000000794. Epub 2023 Jun 27.
4
Annual report on National Clinical Database 2020 for gastroenterological surgery in Japan.日本2020年胃肠外科全国临床数据库年度报告。
Ann Gastroenterol Surg. 2023 Feb 9;7(3):367-406. doi: 10.1002/ags3.12662. eCollection 2023 May.
5
Risk model for mortality associated with esophagectomy via a thoracic approach based on data from the Japanese National Clinical Database on malignant esophageal tumors.基于日本全国恶性食管肿瘤临床数据库数据的经胸食管切除术相关死亡风险模型。
Surg Today. 2023 Jan;53(1):73-81. doi: 10.1007/s00595-022-02548-x. Epub 2022 Jul 27.
6
Prognosis of Patients with Esophageal Carcinoma After Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients Based on the Comprehensive Registry of Esophageal Cancer in Japan.常规胸导管切除术后食管癌患者的预后:基于日本食管癌综合登记数据库的 12237 例患者倾向性匹配分析。
Ann Surg. 2023 May 1;277(5):e1018-e1025. doi: 10.1097/SLA.0000000000005340. Epub 2023 Apr 6.
7
Postoperative recurrent laryngeal nerve palsy is associated with pneumonia in minimally invasive esophagectomy for esophageal cancer.术后喉返神经麻痹与食管癌微创食管切除术相关的肺炎有关。
Surg Endosc. 2021 Feb;35(2):837-844. doi: 10.1007/s00464-020-07455-1. Epub 2020 Feb 21.
8
Minimally invasive esophagectomy and radical lymph node dissection without recurrent laryngeal nerve paralysis.微创食管切除术和根治性淋巴结清扫术,不伴喉返神经麻痹。
Surg Endosc. 2020 Jun;34(6):2749-2757. doi: 10.1007/s00464-020-07372-3. Epub 2020 Feb 3.
9
Esophagectomy performed at institutes certified by the Japan Esophageal Society provide long-term survival advantages to esophageal cancer patients: second report analyzing 4897 cases with propensity score matching.日本食管协会认证机构实施的食管癌切除术为食管癌患者带来长期生存优势:采用倾向性评分匹配分析 4897 例病例的二次报告。
Esophagus. 2020 Apr;17(2):141-148. doi: 10.1007/s10388-019-00712-w. Epub 2020 Jan 14.
10
Impact of certification status of the institute and surgeon on short-term outcomes after surgery for thoracic esophageal cancer: evaluation using data on 16,752 patients from the National Clinical Database in Japan.机构和外科医生认证状况对胸段食管癌手术后短期结局的影响:来自日本国家临床数据库 16752 例患者数据的评估。
Esophagus. 2020 Jan;17(1):41-49. doi: 10.1007/s10388-019-00694-9. Epub 2019 Oct 3.